Placebo

(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said...

(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent. AcelRX said its...

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels. The reviewers posted their...

(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent...

Veterinarian Kevin Fitzgerald has an article in the May/June issue of AKC Family Dog magazine titled “Kennel Concerns and Laser Therapy.” I selected the laser therapy segment because it concerns pain therapy and everyone is interested in...

Dear Pharmacist: I've had migraine headaches for 11 years and live on triptan drugs and ibuprofen. There must be something else I can do. Please lend some sensible Suzy insight. — J.C., Tucson, Ariz. Dear J.C.: The sensible thing for me to do is...

NEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red yeast rice doesn't make it work any better, according to a new study. "I expected to see a synergistic effect with red yeast rice, and I was...

When the president and CEO of Boehringer Ingelheim USA starts to talk about the company's most dramatic failure in the last five years, a certain sheepish tone creeps into his voice. He thinks he's going to have to explain the disease the drug was...

AbbVie said Tuesday that it is teaming up with a California drug company to develop an oral treatment for celiac disease. Celiac disease is the most common autoimmune disease, affecting about 6 million people in the U.S. and Europe.  Those affected can'...

Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette. He was head lifeguard at a public pool in Phoenix, where his father owned a liquor store. She worked...

Baxter International Inc. said Tuesday that a late-stage clinical trial of a plasma product it was testing to treat patients with Alzheimer's disease failed to slow cognitive decline and preserve physical function, sending its shares down more than 3...

NEW YORK (Reuters Health) - Fish oil supplements did not prevent heart problems in people who hadn't had a heart attack yet, in a large long-term study from Italy. The study - a gold-standard randomized, controlled trial - tested the effect of omega-3...